Bengtsson S, Bernander S, Brorson J E, Dornbusch K, Forsgren A, Hallander H, Henning C, Holm S, Malmborg A S, Nilsson L
Scand J Infect Dis. 1986;18(3):257-63. doi: 10.3109/00365548609032335.
The in vitro susceptibility to gentamicin, tobramycin, amikacin and netilmicin in septicaemia isolates was followed during 1980-1984 in 6-8 Swedish laboratories. The bacterial distribution was similar over the years and was dominated by Escherichia coli and staphylococci. Resistance to gentamicin was found in 2.3-3.6%, to tobramycin in 1.4-3.4%, to amikacin and netilmicin in 0.5-0.9%. Production of aminoglycoside modifying enzymes was observed among resistant strains.
1980年至1984年期间，瑞典6至8个实验室对败血症分离株进行了庆大霉素、妥布霉素、阿米卡星和奈替米星的体外药敏试验。多年来细菌分布相似，以大肠杆菌和葡萄球菌为主。庆大霉素耐药率为2.3%至3.6%，妥布霉素耐药率为1.4%至3.4%，阿米卡星和奈替米星耐药率为0.5%至0.9%。在耐药菌株中观察到氨基糖苷类修饰酶的产生。
